Smith Group Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,350
| Closed | -$129K | – | 343 |
|
|
2020
Q2 | $129K | Sell |
1,350
-20
| -1% | -$1.91K | 0.01% | 183 |
|
|
2020
Q1 | $123K | Hold |
1,370
| – | – | 0.01% | 198 |
|
|
2019
Q4 | $73K | Hold |
1,370
| – | – | ﹤0.01% | 256 |
|
|
2019
Q3 | $54K | Buy |
1,370
+530
| +63% | +$20.9K | ﹤0.01% | 274 |
|
|
2019
Q2 | $35K | Hold |
840
| – | – | ﹤0.01% | 301 |
|
|
2019
Q1 | $39K | Sell |
840
-2,700
| -76% | -$125K | ﹤0.01% | 318 |
|
|
2018
Q4 | $154K | Buy |
+3,540
| New | +$154K | 0.01% | 260 |
|
|
2016
Q3 | – | Sell |
-5,940
| Closed | -$202K | – | 501 |
|
|
2016
Q2 | $202K | Buy |
+5,940
| New | +$202K | 0.01% | 259 |
|
|
2015
Q2 | – | Sell |
-23,090
| Closed | -$879K | – | 441 |
|
|
2015
Q1 | $879K | Sell |
23,090
-1,800
| -7% | -$68.5K | 0.03% | 179 |
|
|
2014
Q4 | $970K | Sell |
24,890
-2,510
| -9% | -$97.8K | 0.03% | 183 |
|
|
2014
Q3 | $828K | Buy |
+27,400
| New | +$828K | 0.03% | 183 |
|